Molecular pathogenesis of non-Hodgkin's lymphoma: The role of Bcl-6

Leukemia and Lymphoma

Volumn 44, Issue SUPPL. 3, 2003, Pages

  Pasqualucci, Laura ^a   Bereshchenko, Oxana ^a   Niu, Huifeng ^a   Klein, Ulf ^a   Basso, Katia ^a   Guglielmino, Roberta ^a   Cattoretti, Giorgio ^a   Dalla Favera, Riccardo ^a  

^a Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

Bcl 6; Diffuse large B cell lymphoma; Germinal center; Non Hodgkin's lymphoma; Pathogenesis; Somatic hypermutation

Indexed keywords

HISTONE; HISTONE DEACETYLASE; NICOTINAMIDE; PHOSPHOPROTEIN; PROTEIN BCL 6; SILENT INFORMATION REGULATOR PROTEIN 2; TRANSCRIPTION FACTOR; TRICHOSTATIN A; VORINOSTAT; ZINC FINGER PROTEIN;

5' UNTRANSLATED REGION; ACETYLATION; APOPTOSIS; B CELL LYMPHOMA; B LYMPHOCYTE; CELL CYCLE; CHROMOSOME 3Q; CHROMOSOME BAND; CHROMOSOME TRANSLOCATION; DOWN REGULATION; DRUG MECHANISM; FOLLICULAR LYMPHOMA; GENE REPRESSION; GERMINAL CENTER; IMMUNOGLOBULIN VARIABLE REGION; LARGE CELL LYMPHOMA; LYMPHOCYTE ACTIVATION; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE MIGRATION; NONHODGKIN LYMPHOMA; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEIN MODIFICATION; REVIEW; SOMATIC HYPERMUTATION; SOMATIC MUTATION; TRANSCRIPTION INITIATION; TRANSCRIPTION REGULATION;

EID: 1042303640     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.1080/10428190310001621588     Document Type: Review

References (67)

1. Klein, U., Goosens, T., Fischer, M., Kanzler, H., Braeuninger, A., Rajewsky, K. and Kuppers, R. (1998) "Somatic hypermutation in normal and transformed human B-cells", Immunology Reviews, 162, 261-280.
2. Johansson, B., Mertens, F. and Mitelman, F. (1996) "Primary vs. secondary neoplasia associated chromosomal abnormalities - balanced rearrangements vs. genomic imbalance?", Genes, Chromosomes & Cancer, 16, 155-163.
3. Mitelman, F., Mertens, F. and Johansson, B. (1997) "A breakpoint map of recurrent chromosomal rearrangements in human neoplasia", Nature Genetics, 15, 417-474.
4. Morris, S.W., Kirstein, M.N., Valentine, M.B., Dittmer, K.G., Shapiro, D.N., Saltman, D.L. and Look, A.T. (1994) "Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin's lymphoma", Science, 263, 1281-1284.
5. Dierlamm, J., Baens, M., Wlodarska, I., Stefanova-Ouzounova, M., Hernandez, J.M., Hossfeld, D.K., et al. (1999) "The apoptosis inhibitor gene AP12 and a novel 18q gene, MLT, are recurrently rearranged in the t(11;18)(q21;q21) associated with mucosa-associated lymphoid tissue lymphomas", Blood, 93, 3601-3609.
6. Dalla-Favera, R. and Gaidano, G. (2001) Molecular biology of lymphomas. In Cancer. Principles and Practice of Oncology, edited by V.T.J. De Vita, S. Hellman and S.A. Rosenberg. Pp. 2215-2235. Philadelphia: Lippincott Williams & Wilkins.
7. Harris, N.L., Stein, H., Coupland, S.E., Hummel, M., Favera, R.D., Pasqualucci, L. and Chan, W.C. (2001) "New approaches to lymphoma diagnosis", Hematology (Am Soc Hematol Educ Program), 194-220.
8. McDonnel, T.J. and Korsmeyer, S.J. (1991) "Progression from lymphoid hyperplasia to high grade malignant lymphoma in mice transgenic for the t(14;18)", Nature, 349, 254-256.
9. Adams, J.M. and Cory, S. (1985) "Myc oncogene activation in B and T lymphoid tumours", Proceedings of The Royal Society of London. Series B. Biological Sciences 226, 59-72.
10. Küppers, R. and Dalla-Favera, R. (2001) "Mechanisms of chromosomal translocation in B-cell lymphoma", Oncogene, 20, 5580-5594.
11. Neuberger, M.S. and Milstein, C. (1995) "Somatic hypermutation", Current Opinions in Immunology, 7, 248-254.
12. Goossens, T., Klein, U. and Küppers, R. (1998) "Frequent occurrence of deletions and duplications during somatic hypermutation: implications for oncogene translocations and heavy chain disease", Proceedings of the National Academy of Sciences of the United States of America, 93, 13979-13984.
13. Rogozin, I.B. and Kolchanov, N.A. (1992) "Somatic hypermutagenesis in immunoglobulin genes. II. Influence of neighbouring base sequences on mutagenesis", Biochimica et Biophysica Acta, 1171, 11-18.
14. Muramatsu, M., Kinoshita, K., Fagarasan, S., Yamada, S., Shinkai, Y. and Honjo, T. (2000) "Class switch recombination and hypermutation require activation-induced cytidine deaminase (AID), a potential RNA editing enzyme", Cell, 102, 553-563.
15. Bross, L., Fukita, Y., McBlane, F., Demolliere, C., Rajewsky, K. and Jacobs, H. (2000) "DNA double-strand breaks in immunoglobulin genes undergoing somatic hypermutation", Immunity, 13, 589-597.
16. Papavasiliou, F.N. and Schatz, D.G. (2000) "Cell-cycle-regulated DNA double-stranded breaks in somatic hypermutation of immunoglobulin genes", Nature, 408, 216-221.
17. Pasqualucci, L., Migliazza, A., Fracchiolla, N., William, C., Neri, A., Baldini, L., et al. (1998) "Bcl-6 mutations in normal germinal center B-cells: evidence of somatic hypermutation acting outside Ig loci", Proceedings of the National Academy of Sciences of the United States of America, 95, 11816-11821.
18. Peng, H.Z., Du, M.Q., Koulis, A., Aiello, A., Dogan, A., Pan, L.X. and Isaacson, P.G. (1999) "Nonimmunoglobulin gene hypermutation in germinal center B-cells", Blood, 93, 2167-2172.
19. Shen, H.M., Peters, A., Baron, B., Zhu, X. and Storb, U. (1998) "Mutation of BCL-6 gene in normal B-cells by the process of somatic hypermutation of Ig genes. Science, 280, 1750-1752.
20. Müschen, M., Re, D., Jungnickel, B., Diehl, V., Rajewsky, K. and Kuppers, R. (2000) "Somatic mutation of the CD95 gene in human B-cells as a side-effect of the germinal center reaction", Journal of Experimental Medicine, 192, 1833-1840.
21. Storb, U., Peters, A., Klotz, E., Kim, N., Shen, H.M., Hackett, J., et al. (1998) "Cis-acting sequences that affect somatic hypermutation of Ig genes", Immunological Reviews, 162, 153-160.
22. Pasqualucci, L., Migliazza, A., Basso, K., Houldsworth, J., Chaganti, R.S. and Dalla-Favera, R. (2003) "Mutations of the BCL-6 proto-oncogene disrupt its negative autoregulation in diffuse large B-cell lymphoma", Blood, 101, 2914-2923.
23. Wang, X., Li, Z., Naganuma, A. and Ye, B.H. (2002) "Negative autoregulation of BCL-6 is bypassed by genetic alterations in diffuse large B-cell lymphomas", Proceedings of the National Academy of Sciences of the United States of America, 99, 15018-15023.
24. Landowski, T.H., Qu, N., Buyuksal, I., Painter, J.S. and Dalton, W.S. (1997) "Mutations in the Fas antigen in patients with multiple myeloma", Blood, 90, 4266-4270.
25. Gronbaek, K., Straten, P.T., Ralfkiaer, E., Ahrenkiel, V., Andersen, M.K., Hansen, N.E., et al. (1998) "Somatic Fas mutations in non-Hodgkin's lymphoma: association with extranodal disease and autoimmunity", Blood, 92, 3018-3024.
26. Takakuwa, T., Dong, Z., Takayama, H., Matsuzuka, F., Nagata, S. and Aozasa, K. (2001) "Frequent mutations of Fas gene in thyroid lymphoma", Cancer Research, 61, 1382-1385.
27. Pasqualucci, L., Neumeister, P., Goossens, T., Nanjangud, G., Chaganti, R.S., Kuppers, R. and Dalla-Favera, R. (2001) "Hypermutation of multiple proto-oncogenes in B-cell diffuse large-cell lymphoma", Nature, 412, 341-346.
28. Cigudosa, J.C., Parsa, N.Z., Louie, D.C., Filippa, D.A., Jhanwar, S.C., Johansson, B., et al. (1999) "Cytogenetic analysis of 363 consecutively ascertained diffuse large B-cell lymphomas", Genes, Chromosomes & Cancer, 25, 123-133.
29. Harris, N.L., Jaffe, E.S., Stein, H., Banks, P.M., Chan, J.K., Cleary, M.L., et al. (1994) "A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group", Blood, 84, 1361-1392.
30. Chao, D.T. and Korsmeyer, S.J. (1998) "BCL-2 family: regulators of cell death", Annual Review of Immunology, 16, 395-419.
31. Houldsworth, J., Mathew, S., Rao, P.H., Dyomina, K., Louie, D.C., Parsa, N., et al. (1996) "REL proto-oncogene is frequently amplified in extranodal diffuse large cell lymphoma", Blood, 87, 25-29.
32. Hauptschein, R.S., Gamberi, B., Rao, P.H., Frigeri, F., Scotto, L., Venkatraj, V.S., et al. (1988) "Cloning and mapping of human chromosome 6q26-q27 deleted in B-cell non-Hodgkin lymphoma and multiple tumor types", Genomics, 50, 170-186.
33. Baron, B.W., Nucifora, G., McCabe, N., Espinosa, R. 3rd, Le Beau, M.M. and McKeithan, T.W. (1993) "Identification of the gene associated with the recurring chromosomal translocations t(3;14)(q27;q32) and t(3;22)(q27;q11) in B-cell lymphomas", Proceedings of the National Academy of Sciences of the United States of America, 90, 5262-5266.
34. Kerckaert, J.P., Deweindt, C., Tilly, H., Quief, S., Lecocq, G. and Bastard, C. (1993) "LAZ3, a novel zinc-finger encoding gene, is disrupted by recurring chromosome 3q27 translocations in human lymphomas", Nature Genetics, 5, 66-70.
35. Ye, B.H., Lista, F., Lo Coco, F., Knowles, D.M., Offit, K., Chaganti, R. S. and Dalla-Favera, R. (1993) "Alterations of a zinc finger-encoding gene, Bcl-6, in diffuse large-cell lymphoma", Science, 262, 747-750.
36. Miki, T., Kawamata, N., Hirosawa, S. and Aoki, N. (1994) "Gene involved in the 3q27 translocation associated with B-cell lymphoma, BCL5, encodes a Kruppel-like zinc-finger protein", Blood, 83, 26-32.
37. Dalla-Favera, R., Migliazza, A., Chang, C.C., Niu, H., Pasqualucci, L., Butler, M., et al. (1999) "Molecular pathogenesis of B-cell malignancy: the role of Bcl-6", Current Topics in Microbiology and Immunology, 246, 257-263; discussion 263-265.
38. Zollman, S., Godt, D., Prive, G.G., Couderc, J.L. and Laski, F.A. (1994) "The BTB domain, found primarily in zinc finger proteins, defines an evolutionarily conserved family that includes several developmentally regulated genes in Drosophila", Proceedings of the National Academy of Sciences of the United States of America, 91, 10717-10721.
39. Chang, C.C., Ye, B.H., Chaganti, R.S. and Dalla-Favera, R. (1996) "Bcl-6, a POZ/zinc-finger protein, is a sequence-specific transcriptional repressor", Proceedings of the National Academy of Sciences of the United States of America, 93, 6947-6952.
40. Niu, H., Ye, B.H. and Dalla-Favera, R. (1998) "Antigen-receptor signaling induces MAP kinase-mediated phosphorylation and degradation of the Bcl-6 transcription factor", Genes & Development, 12, 1953-1961.
41. Cattoretti, G., Chang, C.C., Cechova, K., Zhang, J., Ye, B.H., Falini, B., et al. (1995) "Bcl-6 protein is expressed in germinal-center B-cells", Blood, 86, 45-53.
42. Onizuka, T., Moriyama, M., Yamochi, T., Kuroda, T., Kazama, A., Kanazawa, N., et al. (1995) "Bcl-6 gene product, a 92 to 98-kD nuclear phosphoprotein, is highly expressed in germinal center B-cells and their neoplastic counterparts", Blood, 86, 28-37.
43. Rajewsky, K. (1996) "Clonal selection and learning in the antibody system", Nature, 381, 751-758.
44. Ye, B.H., Cattoretti, G., Shen, Q., Zhang, J., Hawe, N., de Waard, R., et al. (1997) "The Bcl-6 proto-oncogene controls germinal-centre formation and Th2-type inflammation", Nature Genetics, 16, 161-170.
45. Shaffer, A.L., Yu, X., He, Y., Boldrick, J., Chan, E.P. and Staudt, L.M. (2000) "Bcl-6 represses genes that function in lymphocyte differentiation, inflammation, and cell-cycle control", Immunity, 13, 199-212.
46. Reljic, R., Wagner, S.D., Peakman, L.J. and Fearon, D.T. (2000) "Suppression of signal transducer and activator of transcription 3-dependent B lymphocyte terminal differentiation by Bcl-6", Journal of Experimental Medicine, 192, 1841-1848.
47. Allman, D., Jain, A., Dent, A., Maile, R.R., Selvaggi, T., Kehry, M.R. and Staudt, L.M. (1996) "Bcl-6 expression during B-cell activation", Blood, 87, 5257-5268.
48. Niu, H., Cattoretti, G. and Dalla-Favera, R. (2003) "BCL6 controls the expression of the B7-1/CD80 co-stimulatory receptor in germinal-center B-cells", Journal of Experimental Medicine, 198, 211-221.
49. Dent, A.L., Shaffer, A.L., Yu, X., Allman, D. and Staudt, L.M. (1997) "Control of inflammation, cytokine expression, and germinal-center formation by Bcl-6", Science, 276, S89-S92.
50. Harris, M.B., Chang, C.C., Berton, M.T., Danial, N.N., Zhang, J., Kuehner, D., et al. (1999) "Transcriptional repression of Stat6-dependent interleukin-4-induced genes by Bcl-6: specific regulation of epsilon transcription and immunoglobulin E switching", Molecular and Cellular Biology, 19, 7264-7275.
51. Ye, B.H., Chaganti, S., Chang, C.C., Niu, H., Corradini, P., Chaganti, R.S. and Dalla-Favera, R. (1995) "Chromosomal translocations cause deregulated Bcl6 expression by promoter substitution in B-cell lymphoma", EMBO Journal, 14, 6209-6217.
52. Migliazza, A., Martinotti, S., Chen, W., Fusco, C., Ye, B.H., Knowles, D.M., et al. (1995) "Frequent somatic hypermutation of the 5′ noncoding region of the Bcl-6 gene in B-cell lymphoma", Proceedings of the National Academy of Sciences of the United States of America, 92, 12520-12524.
53. Bereshchenko, O.R., Gu, W. and Dalla-Favera, R. (2002) "Acetylation inactivates the transcriptional repressor Bcl-6", Nature Genetics, 32, 606-613.
54. Sterner, D.E. and Berger, S.L. (2000) "Acetylation of histones and transcription-related factors", Microbiology and Molecular Biology Reviews, 64, 435-459.
55. Barlev, N.A., Liu, L., Chehab, N.H., Mansfield, K., Harris, K.G., Halazonetis, T.D. and Berger, S.L. (2001) "Acetylation of p53 activates transcription through recruitment of coactivators/histone acetyltransferases", Molecular Cell, 8, 1243-1254.
56. Gu, W. and Roeder, R.G. (1997) "Activation of p53 sequence-specific DNA binding by acetylation of the p53 C-terminal domain", Cell, 90, 595-606.
57. Cress, W.D. and Seto, E. (2000) "Histone deacetylases, transcriptional control, and cancer", Journal of Cellular Physiology, 184, 1-16.
58. Imai, S., Armstrong, C.M., Kaeberlein, M. and Guarente, L. (2000) "Transcriptional silencing and longevity protein Sir2 is an NAD-dependent histone deacetylase". Nature, 403, 795-800.
59. Vaziri, H., Dessain, S.K., Ng Eaton, E., Imai, S.I., Frye, R.A., Pandita, T.K., et al. (2001) "hSIR2(SIRT1) functions as an NAD-dependent p53 deacetylase", Cell, 107, 149-159.
60. Luo, J., Nikolaev, A.Y., Imai, S., Chen, D., Su, F., Shiloh, A., et al. (2001) "Negative control of p53 by Sir2alpha promotes cell survival under stress", Cell, 107, 137-148.
61. Luo, J., Su, F., Chen, D., Shiloh, A. and Gu, W. (2000) "Deacetylation of p53 modulates its effect on cell growth and apoptosis", Nature, 408, 377-381.
62. Polyak, K., Xia, Y., Zweier, J.L., Kinzler, K.W. and Vogelstein, B. (1997) "A model for p53-induced apoptosis", Nature, 389, 300-305.
63. Marks, P.A., Richon, V.M. and Rifkind, R.A. (2000) "Histone deacetylase inhibitors: inducers of differentiation or apoptosis of transformed cells", Journal of the National Cancer Institute, 92, 1210-1216.
64. Moller, M.B., Gerdes, A.M., Skjodt, K., Mortensen, L.S. and Pedersen, N.T. (1999) "Disrupted p53 function as predictor of treatment failure and poor prognosis in B- and T-cell non-Hodgkin's lymphoma", Clinical Cancer Research, 5, 1085-1091.
65. Wolffe, A.P. (1992) Chromatin: Structure and Function. London: Academic Press.
66. Grunstein, M. (1990) "Nucleosomes: regulators of transcription", Trends in Genetics, 6, 395-400.
67. Pak, D.T., Pflumm, M., Chesnokov, I., Huang, D.W., Kellum, R., Marr, J., et al. (1997) "Association of the origin recognition complex with heterochromatin and HP1 in higher eukaryotes", Cell, 91, 311-323.